DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver Metastases

NCT06177288 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

COMBINATION_PRODUCT: DEBIRI Combined With Chemotherapy and Bevacizumab

Sponsor

Fudan University